Summit Global Investments’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$757K Buy
27,034
+3,841
+17% +$126K 0.04% 251
2025
Q4
$868K Sell
23,193
-6,952
-23% -$229K 0.05% 224
2025
Q3
$831K Buy
30,145
+9,404
+45% +$324K 0.05% 226
2025
Q2
$655K Sell
20,741
-8,441
-29% -$272K 0.04% 264
2025
Q1
$969K Sell
29,182
-1,108
-4% -$39.7K 0.07% 173
2024
Q4
$1.04M Buy
30,290
+11,027
+57% +$379K 0.07% 205
2024
Q3
$771K Sell
19,263
-901
-4% -$31.6K 0.05% 280
2024
Q2
$608K Buy
20,164
+807
+4% +$24.3K 0.04% 314
2024
Q1
$650K Buy
19,357
+3,184
+20% +$102K 0.05% 286
2023
Q4
$522K Buy
+16,173
New +$451K 0.03% 332
2023
Q3
Sell
-9,827
Closed -$346K 559
2023
Q2
$346K Buy
+9,827
New +$339K 0.02% 399

Other funds holding HRMY